Dasatinib is effective in imatinib-resistant CML

MLA

Emma Cannell. “Dasatinib Is Effective in Imatinib-Resistant CML.” The Lancet Oncology, vol. 8, Apr. 2007, p. 286. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a67352474f4da15fa1a7d3deb57d0ede&authtype=sso&custid=ns315887.

APA

Emma Cannell. (2007). Dasatinib is effective in imatinib-resistant CML. The Lancet Oncology, 8, 286.

Chicago

Emma Cannell. 2007. “Dasatinib Is Effective in Imatinib-Resistant CML.” The Lancet Oncology 8 (April): 286. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a67352474f4da15fa1a7d3deb57d0ede&authtype=sso&custid=ns315887.